3CH6

Crystal Structure of 11beta-HSD1 Double Mutant (L262R, F278E) Complexed with (3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.35 Å
  • R-Value Free: 0.230 
  • R-Value Work: 0.187 

wwPDB Validation 3D Report Full Report


This is version 1.2 of the entry. See complete history

Literature

Pyridine amides as potent and selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1

Wang, H.Ruan, Z.Li, J.J.Simpkins, L.M.Smirk, R.A.Wu, S.C.Hutchins, R.D.Nirschl, D.S.Van Kirk, K.Cooper, C.B.Sutton, J.C.Ma, Z.Golla, R.Seethala, R.Salyan, M.E.Nayeem, A.Krystek, S.R.Sheriff, S.Camac, D.M.Morin, P.E.Carpenter, B.Robl, J.A.Zahler, R.Gordon, D.A.Hamann, L.G.

(2008) Bioorg.Med.Chem.Lett. 18: 3168-3172

  • DOI: 10.1016/j.bmcl.2008.04.069

  • PubMed Abstract: 
  • Several series of pyridine amides were identified as selective and potent 11beta-HSD1 inhibitors. The most potent inhibitors feature 2,6- or 3,5-disubstitution on the pyridine core. Various linkers (CH(2)SO(2), CH(2)S, CH(2)O, S, O, N, bond) between ...

    Several series of pyridine amides were identified as selective and potent 11beta-HSD1 inhibitors. The most potent inhibitors feature 2,6- or 3,5-disubstitution on the pyridine core. Various linkers (CH(2)SO(2), CH(2)S, CH(2)O, S, O, N, bond) between the distal aryl and central pyridyl groups are tolerated, and lipophilic amide groups are generally favored. On the distal aryl group, a number of substitutions are well tolerated. A crystal structure was obtained for a complex between 11beta-HSD1 and the most potent inhibitor in this series.


    Organizational Affiliation

    Bristol-Myers Squibb Research and Development, PO Box 5400, Princeton, NJ 08543-5400, USA. haixia.wang@bms.com




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Corticosteroid 11-beta-dehydrogenase isozyme 1
A, B, D, E
286Homo sapiensMutation(s): 2 
Gene Names: HSD11B1 (HSD11, HSD11L, SDR26C1)
EC: 1.1.1.146
Find proteins for P28845 (Homo sapiens)
Go to Gene View: HSD11B1
Go to UniProtKB:  P28845
Small Molecules
Ligands 2 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
NAP
Query on NAP

Download SDF File 
Download CCD File 
A, B, D, E
NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE
2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE
C21 H28 N7 O17 P3
XJLXINKUBYWONI-NNYOXOHSSA-N
 Ligand Interaction
311
Query on 311

Download SDF File 
Download CCD File 
A, B, D, E
(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone
C20 H23 F N2 O
SIDDLTBLAQYZIZ-UHFFFAOYSA-N
 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
311IC50: 0.1 nM (100) BINDINGDB
311IC50: 0.1 nM BINDINGMOAD
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.35 Å
  • R-Value Free: 0.230 
  • R-Value Work: 0.187 
  • Space Group: P 21 21 21
Unit Cell:
Length (Å)Angle (°)
a = 74.500α = 90.00
b = 94.300β = 90.00
c = 167.000γ = 90.00
Software Package:
Software NamePurpose
SCALEPACKdata scaling
AMoREphasing
BUSTER-TNTrefinement
PDB_EXTRACTdata extraction
HKL-2000data scaling
TNTrefinement
HKL-2000data reduction
DENZOdata reduction

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

  • Deposited Date: 2008-03-07 
  • Released Date: 2008-06-10 
  • Deposition Author(s): Sheriff, S.

Revision History 

  • Version 1.0: 2008-06-10
    Type: Initial release
  • Version 1.1: 2011-07-13
    Type: Version format compliance
  • Version 1.2: 2017-10-25
    Type: Refinement description